Leonardo is a psychologist, has a Master’s degree in Clinical Psychology and is a PhD fellow at the Pontifícia Universidade Católica do Rio Grande do Sul. He is also one of the directors of the Wainer Group. Leonardo is an Advanced Level Schema Therapist and Supervisor. Leonardo is the current Media Coordinator of International Society of Schema Therapy and is a founding member of the Brazilian Association of Schema Therapy.
Schema Therapy and the Transdiagnostic Model
Co-Presented with André Kolb & Jorge Gustavo Azpiroz
The upcoming symposium is poised to be an exploration into the integration of the transdiagnostic model with Schema Therapy. This event seeks to unravel the complexities of addressing common underlying factors that transcend traditional diagnostic boundaries, offering a fresh perspective on therapeutic interventions for individuals with personality disorders. The symposium will delve into the core principles of Schema Therapy, examining how this modality can effectively address transdiagnostic features present in diverse personality disorders. The presentation will showcase empirical evidence and a teorethical framework of ST and the Transdiagnostic Model. Attendees can expect to gain insights into tailoring interventions that go beyond conventional diagnostic categories, providing a more comprehensive and nuanced approach to treatment. The presenters will discuss the practical implications of transdiagnostic schema work, emphasizing the importance of identifying and modifying maladaptive schemas that cut across different personality disorder presentations. The symposium will offer attendees hands-on experience in applying transdiagnostic principles within the framework of Schema Therapy, fostering a deeper understanding of the therapeutic process. Furthermore, the symposium will encourage a collaborative dialogue among professionals, exploring the challenges and opportunities in transdiagnostic schema-focused work. Discussions will center around adapting traditional therapeutic approaches to better suit the unique needs of individuals with personality disorders, transcending the limitations imposed by strict diagnostic categories. This symposium aims to present a different view on conceptualization and treatment of clients within the ST model. Attendees can anticipate gaining valuable insights and practical tools to enhance their clinical practices, fostering a more integrative and nuanced approach to working with individuals who present with complex and overlapping diagnostic features within the context of Schema Therapy.
Evaluation of the Efficacy Evidence of Schema Therapy and Research Agenda
Schema Therapy is an integrative psychotherapeutic model that was developed by Jeffrey Young as an advancement to cognitive-behavioral therapies (Edwards & Arntz, 2012; Young, Klosko, Weishaar, 2008). Schema Therapy was originally developed with the aim of working with individuals with chronic, refractory and personality disorders (Young et al., 2008). Currently, we can see studies that expand this initial focus, such as studies with eating disorders (McIntosh et al., 2016). The therapeutic model has, in recent years, gained greater popularity among clinicians and in trainings. The International Society of Schema Therapy (ISST) has more than 3000 members on five continents. As the approach gains notoriety, it becomes necessary to evaluate the effectiveness of the model and identify for which demands there is evidence where Schema Therapy can and cannot be used. The objective of this presentation is to evaluate most of the research about the effectiveness of the model in its quality and to point out future aims of research.